Literature DB >> 11165968

Prevalence of diastolic dysfunction in normotensive, asymptomatic patients with well-controlled type 2 diabetes mellitus.

M Zabalgoitia1, M F Ismaeil, L Anderson, F A Maklady.   

Abstract

To evaluate the prevalence of left ventricular (LV) diastolic dysfunction in patients with type 2 diabetes mellitus free of cardiovascular disease, we studied 86 normotensive men and women (mean age 46 +/- 6 years) with Doppler echocardiography. All subjects were asymptomatic for ischemic heart disease or heart failure. The traditional transmitral filling patterns were used to characterize diastolic physiology. The Valsalva maneuver was used to differentiate normal from pseudonormal LV filling pattern. All patients had a normal electrocardiogram at rest and a negative result on exercise echocardiography for inducible wall motion abnormalities. Global LV systolic function was normal (mean LV ejection fraction 58%, range 53% to 76%). Diastolic dysfunction was found in 41 subjects (47%) of which 26 (30%) had impaired relaxation and 15 (17%) had a pseudonormal filling pattern. The mean LV mass index was 101 g/m2 (range 86 to 122). All patients with a normal-filling physiology had gender-adjusted normal LV mass index (mean 93 +/- 11 g/m2), whereas 62% of those with either abnormal relaxation (mean 103 +/- 12 g/m2, p <0.001) or a pseudonormal pattern (mean 110 +/- 12 g/m2, p <0.001) had increased LV mass index. No subject in this cohort had restrictive diastolic physiology. In conclusion, diastolic dysfunction in type 2 diabetes mellitus patients is often found despite adequate metabolic control and freedom from clinically detectable heart disease. The Valsalva maneuver can unmask an additional 17% of patients with subclinical abnormal LV filling pattern, who otherwise would be classified as having a normal diastolic physiology. Increased LV mass index is closely associated with abnormal LV filling characteristics.

Entities:  

Mesh:

Year:  2001        PMID: 11165968     DOI: 10.1016/s0002-9149(00)01366-7

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  59 in total

Review 1.  Diabetic heart disease.

Authors:  T H Marwick
Journal:  Heart       Date:  2005-09-13       Impact factor: 5.994

2.  Identification of diabetic cardiomyopathy with cardiac magnetic resonance imaging.

Authors:  Thomas H Marwick
Journal:  Int J Cardiovasc Imaging       Date:  2006-02       Impact factor: 2.357

3.  Tortuosity of coronary arteries: an indicator for impaired left ventricular relaxation?

Authors:  Okan Turgut; Ahmet Yilmaz; Kenan Yalta; Birhan M Yilmaz; Ali Ozyol; Omer Kendirlioglu; Filiz Karadas; Izzet Tandogan
Journal:  Int J Cardiovasc Imaging       Date:  2007-01-10       Impact factor: 2.357

4.  Prevalence, types and factors associated with echocardiographic abnormalities among newly diagnosed diabetic patients at Mulago Hospital.

Authors:  Martin Muddu; Edrisa Mutebi; Charles Mondo
Journal:  Afr Health Sci       Date:  2016-03       Impact factor: 0.927

Review 5.  Implications of ghrelin and hexarelin in diabetes and diabetes-associated heart diseases.

Authors:  Rasha Mofeed Habeeb Mosa; Zhen Zhang; Renfu Shao; Chao Deng; Jiezhong Chen; Chen Chen
Journal:  Endocrine       Date:  2015-02-04       Impact factor: 3.633

6.  Mechanisms of impaired calcium handling underlying subclinical diastolic dysfunction in diabetes.

Authors:  Véronique A Lacombe; Serge Viatchenko-Karpinski; Dmitry Terentyev; Arun Sridhar; Sitaramesh Emani; John D Bonagura; David S Feldman; Sandor Györke; Cynthia A Carnes
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-08-29       Impact factor: 3.619

7.  Risk Factors Associated with Left Ventricular Diastolic Dysfunction in Type 2 Diabetic Patients without Hypertension.

Authors:  Jung Hyun Noh; Joon Hyung Doh; Sung Yun Lee; Tae Nyun Kim; Hyuk Lee; Hwa Young Song; Jeong Hyun Park; Kyung Soo Ko; Byoung Doo Rhee; Dong Jun Kim
Journal:  Korean Diabetes J       Date:  2010-02-28

8.  Cardiac-specific IGF-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathy.

Authors:  Karina Huynh; Julie R McMullen; Tracey L Julius; Joon Win Tan; Jane E Love; Nelly Cemerlang; Helen Kiriazis; Xiao-Jun Du; Rebecca H Ritchie
Journal:  Diabetes       Date:  2010-03-09       Impact factor: 9.461

9.  Association of glucose metabolism with diastolic function along the diabetic continuum.

Authors:  R Stahrenberg; F Edelmann; M Mende; A Kockskämper; H D Düngen; M Scherer; M M Kochen; L Binder; C Herrmann-Lingen; L Schönbrunn; G Gelbrich; G Hasenfuss; B Pieske; R Wachter
Journal:  Diabetologia       Date:  2010-04-13       Impact factor: 10.122

10.  Elevated plasma levels of TNF-alpha and interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders.

Authors:  Wilfried Dinh; Reiner Füth; Werner Nickl; Thomas Krahn; Peter Ellinghaus; Thomas Scheffold; Lars Bansemir; Alexander Bufe; Michael Coll Barroso; Mark Lankisch
Journal:  Cardiovasc Diabetol       Date:  2009-11-12       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.